| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/23/2001 | EP1100822A1 Secreted cysteine rich protein-6 (scrp-6) |
| 05/23/2001 | EP1100814A2 Inhibitors of urokinase and blood vessel formation |
| 05/23/2001 | EP1100808A1 Prostate derived ets factor |
| 05/23/2001 | EP1100797A1 Heterocyclic compounds as inhibitors of rotamase enzymes |
| 05/23/2001 | EP1100794A1 COMPOUNDS SPECIFIC FOR THE HUMAN $g(a) 1d? ADRENERGIC RECEPTOR AND USES THEREOF |
| 05/23/2001 | EP1100792A1 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases |
| 05/23/2001 | EP1100788A1 Substituted quinazoline derivatives |
| 05/23/2001 | EP1100780A1 Novel 2,3,3a,4,9,9a hexahydro-8-hydroxy-1h-benz f]indoles, a method for the production thereof, and their use as medicaments |
| 05/23/2001 | EP1100775A2 2,5-substituted benzolsulfonylureas and thioureas, methods for the production thereof, use thereof and pharmaceutical preparations containing the same |
| 05/23/2001 | EP1100763A1 Diketoacid-derivatives as inhibitors of polymerases |
| 05/23/2001 | EP1100542A2 Peg-urate oxidase conjugates and use thereof |
| 05/23/2001 | EP1100541A1 Hydrogel for the therapeutic treatment of aneurysms |
| 05/23/2001 | EP1100533A2 Anti-apoptotic compositions comprising the r1 subunit of herpes simplex virus ribonucleotide reductase or its n-terminal portion; and uses thereof |
| 05/23/2001 | EP1100530A1 Use of glp-1 and analogues for preventing type ii diabetes |
| 05/23/2001 | EP1100528A2 Use of novel agents inducing cell death in synergy with interferons |
| 05/23/2001 | EP1100526A2 USE OF HC gp-39 IN IMMUNE DISEASES |
| 05/23/2001 | EP1100525A2 Modulation of apoptosis |
| 05/23/2001 | EP1100524A2 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 05/23/2001 | EP1100521A1 C7f2-a novel potassium channel beta-subunit |
| 05/23/2001 | EP1100519A1 Multibinding agents that modulate nmda receptors |
| 05/23/2001 | EP1100510A2 Combined preparation of anti-infectiously active compounds which inhibit the 2-c-methylerythrose-4 metabolic pathway, and inhibitors of lipid metabolism |
| 05/23/2001 | EP1100503A2 Non-imidazole alkylamines as histamine h 3?-receptor ligands and their therapeutic applications |
| 05/23/2001 | EP1100501A1 Pyrrolidine and pyrroline derivatives having effects on serotonin related systems |
| 05/23/2001 | EP1100498A1 Heterocyclic sulphonamide derivatives |
| 05/23/2001 | EP1100497A1 Heterocyclyl sulphonamide derivatives |
| 05/23/2001 | EP1100493A1 INDOLE sPLA 2? INHIBITORS |
| 05/23/2001 | EP1100492A1 INDOLE sPLA 2? INHIBITORS |
| 05/23/2001 | EP1100486A1 Macrophage scavenger receptor antagonists |
| 05/23/2001 | EP1100484A1 Macrophage scavenger receptor antagonists |
| 05/23/2001 | EP1100480A2 Cholinergic agents in the treatment of presbyopia |
| 05/23/2001 | EP1100429A2 Apoptosis proteins |
| 05/23/2001 | EP0900218A4 Heterocyclic compounds |
| 05/23/2001 | EP0788497B1 Bisarylcarbinol derivatives as inhibitors of leukotriene biosynthesis |
| 05/23/2001 | EP0750614B1 Quinazolinyl-amino derivatives having alpha-antagonist activity |
| 05/23/2001 | EP0722431B1 Oxidized carotenoids, retinoids and related conjugated polyenes, and derived fractions and compounds useful as cell-differentiation inducers, cytostatic agents, and anti-tumor agents |
| 05/23/2001 | EP0689536B1 Naphthalene derivatives |
| 05/23/2001 | EP0669827B1 Compositions for the regulation of cytokine activity |
| 05/23/2001 | CN1296494A New compound |
| 05/23/2001 | CN1296492A Fatty acid derivatives of bile acids and bile acid derivatives |
| 05/23/2001 | CN1296488A Bicycle hydroxamic acid derivatives |
| 05/23/2001 | CN1296485A Substituted indolealkanoic acids |
| 05/23/2001 | CN1296481A (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides |
| 05/23/2001 | CN1296478A Histamine H3 receptor ligands |
| 05/23/2001 | CN1296474A Process for alkylating hindered sulfonamides useful in the production of matrix metalloproteinase inhibitors |
| 05/23/2001 | CN1296414A IL-12 enhancement of immune responses to T-isdependent antigens |
| 05/23/2001 | CN1296413A Composition and method for modulating cytokine release in response to genotoxic agents |
| 05/23/2001 | CN1296410A Methods for inhibiting MRP1 |
| 05/23/2001 | CN1296408A Methods for inhibiting MRP1 |
| 05/23/2001 | CN1296011A Purine L-nucleoside, its analogue and use thereof |
| 05/23/2001 | CN1296010A Novel cyano-indole thrombotonin reuptaking inhibitor compound, its preparation process and medicinal compositions having the same |
| 05/23/2001 | CN1295847A Nutritious health care food for treating galactostasis |
| 05/23/2001 | CN1066246C Axial flow valve system for linear compressor |
| 05/23/2001 | CN1066150C Bridged indole as matrix metalloprotease inhibitors |
| 05/23/2001 | CN1066149C Diazepino-indoles as phosphodiesterase IV inhibitors |
| 05/23/2001 | CN1066146C Use of theophylline derivatives for curing and preventing shock state, xanthine derivatives and preparation thereof |
| 05/23/2001 | CN1066145C N-substituted 3-azabicyclo (3,2,0) heptane derivatives and preparing method and use thereof |
| 05/23/2001 | CN1066138C 4-(arylaminomethylene)-2,4-dihydro-3-pyrazolones |
| 05/23/2001 | CN1066055C Productive method for extracting flavonoid compound extract or powder from bamboo leaf |
| 05/23/2001 | CN1066042C Hair regrowth liniment and its preparation method |
| 05/22/2001 | US6235922 Processes and intermediates for preparing benzo-fused azepinone and piperidinone compounds useful in the inhibition of ACE and NEP |
| 05/22/2001 | US6235903 Method for preparing sulfanyl-type endothelin receptor antagonists |
| 05/22/2001 | US6235879 Apoptosis modulators that interact with the Huntington's disease gene |
| 05/22/2001 | US6235877 Peptido-mimetic compounds containing RGD sequence useful as integrin inhibitors |
| 05/22/2001 | US6235785 Methods for identifying and treating resistant tumors |
| 05/22/2001 | US6235782 Method for treating a patient with neoplasia by treatment with a platinum coordination complex |
| 05/22/2001 | US6235776 Method for treating a patient with neoplasia by treatment with a paclitaxel derivative |
| 05/22/2001 | US6235772 Lipoic acid analogs |
| 05/22/2001 | US6235766 1-(p-thienylbenzyl)imidazoles as agonists of angiotensin (1-7) receptors, processes for their preparation, their use, and pharmaceutical preparations comprising them |
| 05/22/2001 | US6235764 Isothiazole derivatives useful as anticancer agents |
| 05/22/2001 | US6235760 Treatment for CNS injuries |
| 05/22/2001 | US6235758 Indole derivatives as 5-HT receptor antagonist |
| 05/22/2001 | US6235757 Substituted heterocycles |
| 05/22/2001 | US6235756 Methods and compositions for inhibition of angiogenesis by thalidomide |
| 05/22/2001 | US6235753 Tumor necrosis factor; autoimmune diseases; antiallergens |
| 05/22/2001 | US6235750 Nitric oxide synthase inhibitor |
| 05/22/2001 | US6235747 6-phenyl-pyridin-2-ylamine derivatives |
| 05/22/2001 | US6235745 Use of 5HT3, antagonists for promoting intestinal lavage |
| 05/22/2001 | US6235742 5-substituted pyrazolo[4,3-D]pyrimidin-7-ones |
| 05/22/2001 | US6235739 5-phenyl-3-pyridazinone derivatives and drug composition containing the same |
| 05/22/2001 | US6235738 Brain disorders; antiischemic agents |
| 05/22/2001 | US6235734 Pyridone-fused azabicyclic- or cytisine derivatives, their preparation and their use in addiction therapy |
| 05/22/2001 | US6235730 3-piperidyl-4-oxoquinazoline derivatives and pharmaceutical compositions comprising the same |
| 05/22/2001 | US6235727 Sulfonylaminophosphinic and sulfonylaminophosphinic acid derivatives, methods for their preparation and use |
| 05/22/2001 | US6235725 Methods and compositions for the prevention of tolerance to medications |
| 05/22/2001 | US6235713 Vascular endothelial growth factor-D (VEGF-D) polypeptides |
| 05/22/2001 | US6235513 IKK-α proteins, nucleic acids and methods |
| 05/22/2001 | US6235512 Nucleic acid encoding polypeptide of defined amino acid sequence which regulates transcription factor, nuclear factor kappa b, activation; hybridization probes and primers; antibodies; diagnosis; therapy |
| 05/22/2001 | US6235497 Viral vector coding rodent transport protein; for treatment of nervous system disorders |
| 05/22/2001 | US6235492 IKK-α proteins, nucleic acids and methods |
| 05/22/2001 | US6235291 Use of a substance P antagonist in a cosmetic composition, and the composition thus obtained |
| 05/22/2001 | US6235285 An isolated polypeptide comprising a heterologous amino acid sequence fused to specific polynucleotide sequence |
| 05/22/2001 | CA2217006C Novel substituted piperazine derivatives having tachykinin receptor antagonists activity |
| 05/22/2001 | CA2013380C Selective adenosine receptor agents |
| 05/17/2001 | WO2001035106A2 Methods for identifying and using amyloid-inhibitory compounds |
| 05/17/2001 | WO2001034827A1 Antisense modulation of rank expression |
| 05/17/2001 | WO2001034800A1 19 human secreted proteins |
| 05/17/2001 | WO2001034799A1 6 human secreted proteins |
| 05/17/2001 | WO2001034775A1 Mesenchymal stem cells and/or progenitor cells, their isolation and use |
| 05/17/2001 | WO2001034654A1 Hedgehog fusion proteins and uses |
| 05/17/2001 | WO2001034643A1 24 human secreted proteins |